Skip to search formSkip to main contentSkip to account menu

FAAH gene

Known as: FAAH, FAAH-1, FATTY ACID AMIDE HYDROLASE 
National Institutes of Health

Related topics

Related topics

3 relations
FA2H genefatty acid alpha-hydroxylasefatty acid amide hydrolase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Computational insights into function and inhibition of fatty acid amide hydrolase.
2014
2014
Emerging drugs for neuropathic pain
Introduction: Neuropathic pain is a costly and disabling condition, which affects up to 8% of the population. Available therapies… 
Highly Cited
2006
Highly Cited
2006
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis
We previously reported that the compound O‐2093 is a selective inhibitor of the reuptake of the endocannabinoid anandamide (AEA… 
Highly Cited
2006
Highly Cited
2006
Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.
The endocannabinoid system consists of two cannabinoid receptors (CB1 and CB2), endogenous ligands (endocannabinoids), and the… 
2006
2006
The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH.
2005
2005
A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons
Highly Cited
2004
Highly Cited
2004
A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase.
2003
2003
Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
The endogenous fatty acid amide anandamide (AEA) has, as a result of its actions on cannabinoid and vanilloid receptors, a number… 
2000
2000
Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate.
Highly Cited
1998
Highly Cited
1998
An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)